var data={"title":"Copper intrauterine device: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Copper intrauterine device: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/712630?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25725738\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Paragard Intrauterine Copper</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658408\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Contraceptive</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658317\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">Females:</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Prevention of pregnancy:</b> Intrauterine: One IUD to be inserted into the uterine cavity; may be inserted at any time during the menstrual cycle as long as it is reasonably certain the woman is not pregnant. A new unit may be inserted immediately after the previous IUD is removed if otherwise appropriate. Do not leave any one system in place for &gt;10 years.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Back-up contraception is not needed with proper insertion (Curtis 2016a). The copper IUD may be inserted within 10 minutes following delivery of the placenta (Curtis 2016b), any time postpartum, or within 7 days following a first or second trimester spontaneous or induced abortion; do not insert if puerperal sepsis or septic abortion is present (Curtis 2016a; Curtis 2016b).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Additional contraceptive dosing considerations:</i> Switching from a different contraceptive: May be inserted immediately as long as it is reasonably certain the woman is not pregnant. Back-up contraception is not needed (Curtis 2016a)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">\n      <b>Emergency contraception (off-label use):</b> A copper IUD may be inserted as an emergency contraceptive within 5 days of the first act of unprotected sex; may also be inserted beyond 5 days of unprotected intercourse if not &gt;5 days after ovulation (Curtis 2016a; Turok 2013; Wu 2010).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658316\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Prevention of pregnancy:</b> Females: Refer to adult dosing; not to be used prior to menarche.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658318\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Not indicated for use in postmenopausal women.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45653200\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Intrauterine Device, Intrauterine: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Paragard Intrauterine Copper: </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45653199\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658319\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Full administration and removal instructions are provided with the device. Insertion should be done by a trained health care provider. Analgesics may be used. Paracervical block using lidocaine may also reduce pain during insertion (Curtis 2016a). Insert into the uterine cavity to the recommended depth with the provided insertion device; do not force into the uterus. Transvaginal ultrasound may be used to check proper placement. Remove if not positioned properly and insert a new IUD; do not reinsert removed IUD. Following insertion, only the threads should be visible; trim so that 3 to 4 cm protrude into the vagina and note the length of the threads in the patient record.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658409\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Contraception:</b> For prevention of pregnancy, intrauterine device (IUD) may be in place for up to 10 years</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25475245\" class=\"block off-label drugH1Div\"><span class=\"drugH1\">Use: Off-Label</span>\n    <p>Emergency contraception</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23646918\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dermatologic: Urticaria (allergic)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Endocrine &amp; metabolic: Hypermenorrhea, spotty menstruation</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Genitourinary: Abnormal vaginal hemorrhage, cervical perforation, dysmenorrhea, dyspareunia, ectopic pregnancy, embedment of intrauterine system in the myometrium, leukorrhea, pelvic cramps, pelvic pain, spontaneous migration of the IUD, uterine perforation, vaginitis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hematologic &amp; oncologic: Anemia</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Miscellaneous: Device expulsion</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Neuromuscular &amp; skeletal: Back pain</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658414\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Allergy to any component of the formulation; pregnancy or suspicion of pregnancy; abnormalities of the uterus resulting in distortion of the uterine cavity; acute pelvic inflammatory disease (PID), or current behavior suggesting a high risk for PID; postpartum endometritis or postabortal endometritis in the past 3 months; known or suspected uterine or cervical malignancy; genital bleeding of unknown etiology; mucopurulent cervicitis; Wilson disease; a previously placed IUD that has not been removed</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658388\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Bleeding irregularities: Menstrual bleeding patterns may be altered with use of the intrauterine device (IUD). Unexplained vaginal bleeding should be evaluated prior to insertion (Curtis 2016b); use is contraindicated with unexplained genital bleeding. If bleeding irregularities develop during use, appropriate diagnostic measures should be taken to rule out endometrial pathology or displacement of the device (Curtis 2016a; Curtis 2016b).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Bradycardia/syncope: Vasovagal reactions (bradycardia or syncope) may occur during insertion of the IUD.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Ectopic pregnancy: If pregnancy occurs with the device in place, evaluate for an ectopic pregnancy. May be used in women with a history of ectopic pregnancy (Curtis 2016b).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Intrauterine pregnancy: The risk of spontaneous abortion, premature delivery, sepsis, septic shock, and death (rare) are increased if an intrauterine pregnancy occurs with the copper IUD in place. If pregnancy occurs, the device should be removed if the strings are visible (pregnancy loss may occur). If the strings are not visible but it is determined that the device is still in place, the woman should be informed of the risks if pregnancy is continued. Premature labor and delivery may also occur.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pelvic inflammatory disease (PID): An increased incidence of PID (may be asymptomatic) and actinomycosis infections have been reported with IUD use. The highest risk of PID is within 20 days of insertion. Administration of antibiotics during device insertion does not decrease the risk of PID. Women with symptomatic PID potentially due to actinomyces should be treated with antibiotics and the IUD should be removed. Due to an increased risk of PID, IUDs are not recommended for women who are at high risk for infection from sexually transmitted organisms. Acute PID or current behavior suggesting a high risk for PID are contraindications to inserting the device.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Bleeding disorders: Thrombocytopenia may increase the risk of bleeding; use caution in women with severe thrombocytopenia who may be at risk of spontaneous bleeding. Prior to initiation of therapy, consultation with a specialist may be required (Curtis 2016b).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Cervical or endometrial cancer: Women diagnosed with cervical or endometrial cancer prior to IUD insertion should not use an IUD for pregnancy prevention (may have in increased risk of bleeding or infection when the device is inserted). Women diagnosed after insertion of an IUD may continue; however, the IUD will most likely need removed during treatment (Curtis 2016b). Use is contraindicated in women with cervical or uterine cancer.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Gestational trophoblastic disease: Women with gestational trophoblastic disease are at increased risk of adverse events if pregnancy occurs; use of a copper IUD may be appropriate for prevention of pregnancy in some situations with close medical supervision. However, women with persistently elevated beta-hCG concentrations or malignant disease with evidence or suspicion of intrauterine disease should not initiate therapy with a copper IUD due to risks of infection, hemorrhage, or perforation. Consider benefits of effective contraception versus risks of continuation/removal in women who have a copper IUD already in place (Curtis 2016b).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Sepsis: The copper IUD should not be inserted in women with postpartum sepsis or immediately following a septic abortion (Curtis 2016b).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Sexually transmitted disease: Use of a copper IUD should not be initiated in women with purulent cervicitis, chlamydial, or gonococcal infection. The IUD does not need to be removed if diagnosis occurs with the IUD in place, as long as there is treatment with appropriate antibiotics, and consideration is given to personal risk factors and patient preference (Curtis 2016b).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Tuberculosis: The copper IUD may be inserted in women with nonpelvic tuberculosis; do not initiate treatment in cases of pelvic infection and consider removal when pelvic infection occurs with the IUD in place (Curtis 2016b).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Wilson disease: There is a theoretical concern that the copper from the IUD may exacerbate Wilson disease. Use is contraindicated in women with Wilson disease.</p>\n    <p style=\"text-indent:0em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Altered immunocompetence: Women with AIDS may use the copper IUD if they are clinically stable on antiretroviral therapy; HIV-infected women may use the copper IUD if they are asymptomatic. Use caution in women with other immunocompromising conditions (limited data) and monitor for infection.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric: Not for use prior to menarche.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Postmenopausal women: Not indicated for use in postmenopausal women.</p>\n    <p style=\"text-indent:0em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Embedment: If partial embedment in the myometrium occurs, removal may become difficult and surgical removal may be required.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Expulsion: Expulsion of the device may occur and most often is reported during menses and within the first few months after insertion. The risk of expulsion is increased in nulliparous women or when the device is inserted immediately after delivery or abortion. If the IUD is not inserted immediately postpartum, the manufacturer recommends waiting until the second postpartum month to decrease the risk of perforation. Insertion following a second trimester abortion is associated with a higher risk of expulsion than when insertion occurs following a first trimester abortion. Insertion into a uterine cavity that is &lt;6 cm may increase the risk of expulsion, bleeding, pain, and perforation. The risk of expulsion may also be increased in lactating women. Unintended pregnancy may occur in the event of an unnoticed expulsion.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Medical diathermy: Nonsurgical short-wave and microwave heat therapy was not shown to significantly elevate intrauterine temperature in a small study of women with a copper IUD. Theoretically, medical diathermy in woman with a metal-containing IUD may cause heat injury to the surrounding tissue.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; MRI: Based on limited data, MRI at the level of 1.5 Tesla is acceptable in women with the copper IUD.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Perforation: Perforation (rare) of the uterine wall or cervix (partial or total) may occur during placement of the device and may not be detected until later. Spontaneous migration may also occur. If perforation occurs, remove the IUD immediately to prevent organ damage from the device as well as adhesions caused by the copper. Imaging followed by laparoscopy or laparotomy may be needed to remove the IUD from the peritoneal cavity. The risk of perforation may also be increased in lactating women (limited data).</p>\n    <p style=\"text-indent:0em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Insertion should be done by a trained health care provider.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Emergency contraception (off-label use): When used for emergency contraception, women were required to have &ge;1 spontaneous normal cycle following discontinued hormonal contraception, or a recent delivery, miscarriage, or induced abortion, plus a negative urine pregnancy test in addition to the usual contraindications to IUD insertion (Wu 2010). The criteria for Copper IUD insertion in non-emergency pregnancy prevention should be applied when used for emergency contraception (Curtis 2016b).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; HIV infection protection: Copper IUDs do not protect against HIV infection or other sexually transmitted diseases.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23358691\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23358688\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=93719&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658412\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Use during pregnancy is contraindicated. An increased risk of birth defects has not been observed from the copper released from the device. However, the risk of spontaneous abortion, premature delivery, sepsis, septic shock, and death (rare) are increased if an intrauterine pregnancy occurs with the IUD in place. Premature labor and delivery may also occur. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658413\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Women may breastfeed while using a copper IUD; an increase in copper breast milk concentrations has not been observed. The risk of perforation with IUD is increased in lactating women (limited data). The copper IUD may be inserted immediately postpartum in breastfeeding women, including women who had a cesarean delivery. The risk of infection is not increased; the risks of expulsion may be increased and this risk should be considered along with the need for effective contraception and patient access to placement at a later time (Curtis 2016b).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658320\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Prior to insertion, assess pregnancy status; bimanual examination and cervical inspection; weight (optional; BMI at baseline may be helpful to monitor changes during therapy); STD screen (unless already screened according to CDC STD treatment guidelines) (Curtis 2016a).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Monitor for vasovagal reactions following insertion. Threads should be visible but length of thread may change over time; remove device if there is evidence that it has become displaced, broken, perforated the uterus, or partially expelled. Transvaginal ultrasound may be used to check placement. Reexamine following first menses postinsertion of IUD. Evaluate for abdominal or pelvic pain, cramping, tenderness, malodorous discharge, infection, bleeding, fever, or missed period. Assess potential health status changes at routine visits (Curtis 2016a).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23658313\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">The mechanism of action is not well defined but may involve interfering with sperm transport, fertilization, and prevention of implantation. A copper IUD may prevent fertilization by interfering with the ability of sperm to reach the fallopian tube, or decrease the sperm's ability to fertilize by causing a foreign body reaction and chemical changes that may be toxic. Implantation can rarely occur with a copper IUD; however, the number of fertilized ova is decreased when compared to sexually active women not using a contraceptive. When fertilized ova are present, they do not develop normally (Rivera, 1999). The number of women with a copper IUD who have an unintended pregnancy within the first year of insertion following typical use and perfect use is &lt;1%. </p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"26287787\"></a>American College of Obstetricians and Gynecologists (AGOG). Practice bulletin no. 152: emergency contraception. Obstet Gynecol. 2015;126(3):e1-e11. doi: 10.1097/01.AOG.0000471180.02939.1a.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/copper-intrauterine-device-drug-information/abstract-text/26287787/pubmed\" target=\"_blank\" id=\"26287787\">26287787</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"27467319\"></a>Curtis KM, Jatlaoui TC, Tepper NK, et al. US selected practice recommendations for contraceptive use, 2016. <i>MMWR Recomm Rep</i>. 2016a;65(4):1&#8208;66. doi: 10.15585/mmwr.rr6504a1.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/copper-intrauterine-device-drug-information/abstract-text/27467319/pubmed\" target=\"_blank\" id=\"27467319\">27467319</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"27467196\"></a>Curtis KM, Tepper NK, Jatlaoui TC, et al. US medical eligibility criteria for contraceptive use, 2016. <i>MMWR Recomm Rep</i>. 2016b;65(3):1&#8208;103. doi: 10.15585/mmwr.rr6503a1.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/copper-intrauterine-device-drug-information/abstract-text/27467196/pubmed\" target=\"_blank\" id=\"27467196\">27467196</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    ParaGard (copper IUD) [prescribing information]. Trumbull, CT: Cooper Surgical Inc; January 2018.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. <i>Am J Obstet Gynecol</i>. 1999;181(5, pt 1):1263-1269.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/copper-intrauterine-device-drug-information/abstract-text/10561657/pubmed\" target=\"_blank\" id=\"10561657\">10561657</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"23945595\"></a>Turok DK, Godfrey EM, Wojdyla D, et al. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle. <i>Hum Reprod</i>. 2013;28(10):2672-2676.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/copper-intrauterine-device-drug-information/abstract-text/23945595/pubmed\" target=\"_blank\" id=\"23945595\">23945595</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"20618314\"></a>Wu S, Godfrey EM, Wojdyla D, et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. <i>BJOG</i>. 2010;117(10):1205-1210.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/copper-intrauterine-device-drug-information/abstract-text/20618314/pubmed\" target=\"_blank\" id=\"20618314\">20618314</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 93719 Version 35.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F25725738\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F23658408\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F23658317\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F23658316\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F23658318\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F45653200\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F45653199\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F23658319\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F23658409\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Use: Off-Label\" href=\"#F25475245\" class=\"outlineLink\">Use: Off-Label</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F23646918\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F23658414\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F23658388\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F23358691\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F23358688\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F23658412\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F23658413\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F23658320\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F23658313\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/93719|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div>","javascript":null}